MedTrace Logo

Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea

NCT04140422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2020-07-15

No results posted yet for this study

Summary

This study evaluates the efficacy of hyperosmolar eye drops on early morning edema of the cornea in patients with Fuchs' endothelial corneal dystrophy (FECD). Each participant will receive hyperosmolar eye drops in one eye and lubricating eye drops in the fellow eye.

Conditions

  • Fuchs' Endothelial Dystrophy

Interventions

OTHER

Hyperosmolar eye drops

Application of one preservative-free hyperosmolar eye drop, when waking up and one eye drop 30 min later to one eye by the investigators

OTHER

Placebo

Application of one preservative-free lubricating eye drop, when waking up and one eye drop 30 min later to the fellow eye by the investigators

Sponsors & Collaborators

  • University Eye Hospital, Freiburg

    lead OTHER

Principal Investigators

  • Katrin Wacker, MD · University of Freiburg, Eye Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-24
Primary Completion
2020-06-25
Completion
2020-06-25

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04140422 on ClinicalTrials.gov